Christian Richter
About Christian Richter
Christian Richter is a Corporate Development Manager EMEA at Materion Corporation, with extensive experience in corporate development and clinical research across various companies in the medical and manufacturing sectors. He holds multiple degrees in Geography, Economics, and Business Administration from the University of Erlangen-Nuremberg, Universidad de Cádiz, and Université de Limoges.
Work at Materion
Christian Richter has been serving as the Corporate Development Manager EMEA at Materion Corporation since 2019. In this role, he is responsible for creating a market-driven strategy for the EMEA region, which includes mid-term planning for sales, capital expenditures, and human resources. He has established a key account organization and realigned the sales process to better serve markets and applications in the region.
Previous Experience at AVIDAL Vascular GmbH
Prior to his current position, Christian Richter worked at AVIDAL Vascular GmbH as the Vice President of Corporate Development & Clinical Research from 2008 to 2011. During his tenure, he contributed to the company's strategic initiatives and clinical research efforts in the medical sector.
Experience at Translumina GmbH
Christian Richter held multiple roles at Translumina GmbH, starting as the Manager of Marketing & Monitoring from 2005 to 2006. He then transitioned to the position of Manager of Clinical Studies from 2006 to 2007. His work involved overseeing clinical studies and marketing strategies within the organization.
Educational Background
Christian Richter studied at the University of Erlangen-Nuremberg, where he earned a Master of Science (M.Sc.) in Geography and a Master of Arts (M.A.) in Economics, both completed between 1998 and 2005. He also studied Business Administration and Management at Universidad de Cádiz and Université de Limoges, completing these programs in 2001 and 2003, respectively.
Achievements in Corporate Development
Christian Richter successfully led the commercial and operational due diligence for the acquisition of Optics Balzers AG, a transaction valued at 160 million USD. He implemented productivity measures at the former Heraeus plant that resulted in an annual cost-saving effect of 2.5 million USD EBIT. Additionally, he identified and qualified channel and manufacturing partners to design customized engineered parts for the EMEA market.